Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
XBB
Description:
XBB is a recombinant sublineage of the SARS-CoV-2 Omicron variant studied in virology and epidemiology.
Primary topic:
SARS-CoV-2 and COVID-19 Research (85%)
Related topics:
SARS-CoV-2 and COVID-19 Research (85%),
SARS-CoV-2 detection and testing (7%)
Wikidata ID:
wiki/Q115983015
OpenAlex ID:
keywords/xbb
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
2022
·
Qian Wang
, Sho Iketani
, et al.
·
Cell
·
914
PDF
Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
2022
·
Yunlong Cao
, Fanchong Jian
, et al.
·
Nature
·
904
PDF
ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
2023
·
Can Yue
, Weiliang Song
, et al.
·
The Lancet Infectious Diseases
·
330
PDF
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB
2022
·
Masaki Imai
, Mutsumi Ito
, et al.
·
New England Journal of Medicine
·
262
PDF
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster
2022
·
Meredith E. Davis-Gardner
, Lilin Lai
, et al.
·
New England Journal of Medicine
·
251
PDF
Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB
2022
·
Ryuta Uraki
, Mutsumi Ito
, et al.
·
The Lancet Infectious Diseases
·
185
PDF
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1
2024
·
Fanchong Jian
, Jing Wang
, et al.
·
Nature
·
180
Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine
2023
·
Nabin K Shrestha
, Patrick C Burke
, et al.
·
Open Forum Infectious Diseases
·
106
Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
2023
·
Ryuta Uraki
, Mutsumi Ito
, et al.
·
The Lancet Infectious Diseases
·
103
PDF
Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants
2024
·
Timothy S. Johnston
, Shuk Hang Li
, et al.
·
Immunity
·
99
An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB
2023
·
Qingwen He
, Lili Wu
, et al.
·
Cell Reports Medicine
·
96
Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study
2023
·
Celine Y Tan
, Calvin J Chiew
, et al.
·
The Lancet Infectious Diseases
·
80
PDF
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern
2025
·
Ankita Saha
, Sounak Ghosh Roy
, et al.
·
Vaccines
·
54
PDF
Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
2023
·
Lidong Wang
, Michelle Møhlenberg
, et al.
·
Cytokine & Growth Factor Reviews
·
52
PDF
Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 – the public health challenges
2023
·
Thirumalaisamy P. Velavan
, Francine Ntoumi
, et al.
·
International Journal of Infectious Diseases
·
50
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models
2023
·
Emiko Urano
, Yumi Itoh
, et al.
·
Science Translational Medicine
·
47
PDF
Primary assessment of the diversity of Omicron sublineages and the epidemiologic features of autumn/winter 2022 COVID-19 wave in Chinese mainland
2023
·
Gang Lu
, Yun Ling
, et al.
·
Frontiers of Medicine
·
47
PDF
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
2023
·
Aiste Dijokaite-Guraliuc
, Raksha Das
, et al.
·
Cell Reports
·
46
PDF
Real-world effectiveness of nirmatrelvir/ritonavir against COVID-19 hospitalizations and severe COVID-19 in community-dwelling elderly Singaporeans during Omicron BA.2, BA.4/5, and XBB transmission
2023
·
Liang En Wee
, An Ting Tay
, et al.
·
Clinical Microbiology and Infection
·
44
PDF
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins
2024
·
Weiwei Li
, Zepeng Xu
, et al.
·
The EMBO Journal
·
42
Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography
2023
·
Annika Rössler
, Antonia Netzl
, et al.
·
Nature Communications
·
42
PDF
Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2
2023
·
Angelin M. Philip
, Wesam S. Ahmed
, et al.
·
Computational and Structural Biotechnology Journal
·
40
PDF
Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
2023
·
Vinit Upasani
, Katie Townsend
, et al.
·
Clinical Infectious Diseases
·
37
PDF
Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines
2023
·
Dedong Li
, Minrun Duan
, et al.
·
New England Journal of Medicine
·
37
PDF
Outpatient randomized controlled trials to reduce COVID‐19 hospitalization: Systematic review and meta‐analysis
2023
·
David J. Sullivan
, Daniele Focosi
, et al.
·
Journal of Medical Virology
·
36
PDF
Show more works
View as search
Works count:
232
Citation count:
5,183
Year
Topic
Type